Increased Receptor Affinity (Hypothesized): Some research suggests that the lack of the N-terminal tripeptide actually enhances its binding affinity to the IGF-1R in damaged or targeted cells, leading to a strong, immediate growth signal that promotes satellite cell recruitment, repair, and growth
Food & Drug Administration (FDA) includes epitalon in its group of peptides that pose a risk of immunogenicity, in which the body reacts to a substance as though it were a threat and mounts an immune response against it.37 The FDA warns that such immune responses can be life-threatening, so epitalon isnt completely safe for everyone.38 In addition, the healthcare providers weve consulted suggest that women who are pregnant or breastfeeding should avoid epitalon, along with other therapeutic peptides, since there isnt enough research to confirm safety for them or their fetus/child
doi: 10.1182/blood-2004-05-1699 7 FanJKamphorstJJMathewRChungMKWhiteEShlomiTet al
It's applied topically post-treatment to support tissue repair, hydration, and skin regeneration
